email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2641-1687

Journal of Urology & Nephrology Studies

Research Aticle(ISSN: 2641-1687)

Efficacy of Combination Dutasteride and Lycopene to Reduce Bleeding in Benign Prostate Hyperplasia [BPH] Post- Transurethral Resection of the Prostate [TURP] Volume 2 - Issue 1

Eriawan Agung Nugroho1*, Siti Amarwati2, Nugroho Akhbar3 and Chemy Wiryawan Cahyono3

  • 1 Division of Urology, Medical Faculty of Diponegoro University, Dr. Kariadi Hospital, Indonesia
  • 2 Division of Pathology Anatomy, Medical Faculty of Diponegoro University, Dr. Kariadi Hospital, Indonesia
  • 3 General Surgery Resident, Medical Faculty of Diponegoro University, Indonesia

Received: June 28, 2019;   Published: July 09, 2019

Corresponding author: Eriawan Agung Nugroho, Division of Urology, Medical Faculty of Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia

DOI: 10.32474/JUNS.2019.02.000132

Abstract PDF

Abstract

References

  1. Nugroho EA, Muslim R, Riwanto I, Soetojo (2015) The efficacy of dutasteride and green tea combination towards angiogenesis and bledding on BPH after TURP: study the effect on VEGF, MVD, and Hb. Internat J Sci Eng 9(2): 80-84.
  2. Berry S, Coffey D, Walsh P, Ewing (1984) The development of human benign prostatic hyperplasia with age. Journal of Urology 132: 474-479.
  3. Fitzpatric JM (2006) The natural history of benign prostatic hyperplasia. BJU Int 97: 3-6.
  4. Hoffman R, MacDonald R, Wilt T (2004) Laser prostatectomy for benign prostatic Cochrane Database of Systematic Reviews (1): CD001987.
  5. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, et al. (2010) American Urological Association Guideline: Management of Benign Prostatic Hyperplasia.
  6. Pujari NR (2016) Transurethral Resection of Prostate is Still the Gold Standard for Small to Moderate Sized Prostates. J Integr Nephrol Androl 3: 68-9.
  7. Walsh PC, Retik AB (1998) Transurethral surgery.In: Campbell’s urology (7th edn), WB saunders. Philadelphia, 1511-28.
  8. Foley CL, Bott SR, Kirby RS (2003) An update on the 5 alpha reductase inhibitor. Timely Top Med Urol
  9. Andriole G, Bruchovsky N, Chung LW (2004) Dihydrotestosterone and the prostate: The scientific rational for 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Journal of Urology 172(4 Pt 1): 1399-403.
  10. Rittmaster RS, Norman RW, Thomas LN (1996) Evidence for atrophy and apoptosis in the prostates of men given finasteride. J Clin Endocrinol Metab 81(2): 814-8
  11. Zong HT, Peng XX, Yang CC, Zhang Y (2011) A systematic review of the effects and mechanisms of preoperative 5a-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia. Asian Journal of Andrology 13: 812-8
  12. Hahn RG, Fagerström T, Tammela T (2007) Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride. Journal Complication BJU International 99: 587-5
  13. Shanmugasundaram R, Singh JC, Kekre NS (2007) Does dutasteride reduce perioperative blood loss and postoperative complications after transurethral resection of the prostate?. Uroscan 23(3): 334-33
  14. Martov AG, Ergakov DV (2008) The experience in dutasteride use before transurethral prostatic resection for large adenoma. Urologiia 4: 46,48-50,52.
  15. Semenza GL(2007) Hypoxia and cancer. Cancer Metastasis 26: 223-2
  16. Winarsi H (2007) Antioksidan dan Radikal Bebas: Potensi dan Aplikasinya Dalam Kesehatan. Penerbit Kanisius Yogya
  17. Febriansah R, Indriyani L, Palupi KD, Ikawati M (2008) Tomat (Solanum lycopersicum L.) Sebagai Agen Kemopreventif Potensial.
  18. Upadhyay J, Kesharwani RK, Misra K (2009) Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity. Bio information 4: 233-36.
  19. Ku JH, Shin JK, Cho MC, Myung JK, Moon KC, et al. (2009) Effect of dutasteride on the expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and microvessel density in rat and human prostate tissue. Scand J Urol Nephrol 43(6): 445-4
  20. Detchokul S, Frauman AG (2011) Recent development in prostate cancer biomarker research: therapeutic implications. Br j Clin Pharmacol 71(2): 157-74.
  21. Kirollos MM, Campbell N (1997) Factors influencing blood loss in transurethral resection of the prostate (TURP) : auditing TURP. Br J Viol 80: 111- 115.
  22. Miyao H, Kotake Y, Kakoi H, Sekiguchi H, Kawazoe T (2001) TURP Syndrome and Changes in Body Fluid Distribution. J Saitama Med School 28 : 1-8.
  23. Boccon Gibod L, Valton M, Ibrahim H, Comenducci A (2005) Effect of Dutasteride on Reduction of Intraoperative Bleeding Related to Transurethral Resection of Prostate. Prog Urol 15(6): 1085 -1089.

https://www.high-endrolex.com/21